Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 70010-133

7 FDA label images from Granules Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 70010-133). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomeprazole-structure (Esomeprazole Structure)

Esomeprazole-structure (Esomeprazole Structure)
Chemical structure of esomeprazole magnesium depicted as two repeating units consisting of a benzimidazole ring substituted with methoxy, methyl groups, and a sulfinyl group connected to magnesium ions with three water molecules.*
FDA Label Image

Esomeprazole-fig2 (Esomeprazole Fig2)

Esomeprazole-fig2 (Esomeprazole Fig2)
A line graph depicting the percent maintained over a 6-month period for Esomeprazole Magnesium Delayed-Release Capsules at 40 mg, 20 mg, and 10 mg doses compared to placebo. The x-axis represents months, and the y-axis represents percent maintained. The graph shows higher maintenance percentages for 40 mg and 20 mg doses compared to 10 mg and placebo groups.*
FDA Label Image

Esomeprazole-fig3 (Esomeprazole Fig3)

Esomeprazole-fig3 (Esomeprazole Fig3)
A line graph showing the percent maintained over 6 months for Esomeprazole magnesium delayed-release capsules at 10 mg, 20 mg, and 40 mg doses compared to placebo. The graph tracks the medication's sustained effect across months with different symbols representing each dose and placebo.*
FDA Label Image

Esomeprazole-fig4 (Esomeprazole Fig4)

Esomeprazole-fig4 (Esomeprazole Fig4)
A line graph showing the percentage of patients symptom-free over 28 diary days for three groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and placebo. The y-axis represents percent symptom-free, and the x-axis shows diary days from 0 to 28.*
FDA Label Image

Esomeprazole-fig5 (Esomeprazole Fig5)

Esomeprazole-fig5 (Esomeprazole Fig5)
Line graph showing the percent of patients symptom-free over 28 diary days for Esomeprazole Magnesium Delayed-Release Capsules 20 mg and 40 mg compared to placebo. The graph tracks three groups, indicating symptom-free percentages on the y-axis and diary days on the x-axis, illustrating variations among the 20 mg, 40 mg, and placebo groups over time.*
FDA Label Image

Esomeprazole-20-mg-30s-label (Esomeprazole 20 mg 30s Label)

Esomeprazole-20-mg-30s-label (Esomeprazole 20 mg 30s Label)
Label for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg strength. The label includes NDC 70010-133-03, states the product contains 30 capsules, and is for Rx only. Manufacturer information lists Granules India Limited, Hyderabad, India, and Granules Pharmaceuticals Inc., Chantilly, VA. The label also displays storage instructions and a barcode, with a designated area for batch coding and a 2D barcode section.*
FDA Label Image

Esomeprazole-40-mg-30s-label (Esomeprazole 40 mg 30s Label)

Esomeprazole-40-mg-30s-label (Esomeprazole 40 mg 30s Label)
Label for Esomeprazole Magnesium Delayed-Release Capsules, USP 40 mg by Granules Pharmaceuticals Inc. The label shows the NDC number 70010-134-03, indicates 30 capsules per container for oral use, and states the product is Rx only. It includes storage instructions, manufacturer details, and a barcode. The label also notes the active ingredient content as 40 mg esomeprazole equivalent to 44.5 mg esomeprazole magnesium trihydrate USP.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.